Centricity Research’s Post

⌛Register for this webinar before time runs out⌛ Autoimmune patients face intricate health challenges, often dealing with multiple conditions simultaneously. It's a journey filled with concern for their present and future well-being, both for patients and clinicians. ⭐ Dive into a 90-minute masterclass with clinical naturopath and fx Medicine ambassador Emma Sutherland. Gain insights into her clinical practice secrets, simplifying assessment and treatment of complex autoimmunity. In this session, Emma will discuss: 📚 Her holistic approach to complex cases 🚙 Key drivers of autoimmune disease 🔍 Strategies for correct assessment and diagnosis for patients 🤝 Successful approaches for improving patient compliance 🌱 Methods for achieving better health outcomes Discover how to streamline your approach, tailor patient care, and explore effective treatment options. 👉 Grab Your Ticket Now! Secure your spot through the link below 👇 https://bit.ly/4cWYB7b #fxmedicine #clinicalmastery #autoimmune #immunity #microbiome #stress #detoxification #cpe #cpd #naturopath #naturopathic #BioCeuticals

2024 Alzheimer's Disease Facts and Figures. Learn more about this and other topics in the latest Optum HospiLink issue: https://bit.ly/3KQxsG3. To get HospiLink via email, subscribe at bit.ly/3c4Mh7M.   #pharmacy #hospice #palliativecare

Young People with #Diabetes May Face Higher #Alzheimer's Risk   A new study suggests that early-onset diabetes may increase the risk of Alzheimer’s disease. Although the study is small, the results line up with previous findings. Controlling diabetes with lifestyle changes or medication may help lower dementia risk.   https://lnkd.in/edKHkxS2   Creative Medical Technology Holdings Inc. (Nasdaq: CELZ) is at the forefront of innovating regenerative medicine & immunotherapies, targeting improved patient outcomes and quality of life. Our groundbreaking CREATE-1 clinical trial, featuring CELZ-201, offers hope in the treatment of newly diagnosed type 1 diabetes, a condition affecting millions. Dive deeper into our commitment to combatting type 1 diabetes and transforming lives.    #CreativeMedicalTechnology #Type1Diabetes #Innovation

Today is #WorldAsthmaDay, organized by Global Initiative for Asthma. Asthma affects over 260m people globally, about 3% of the population! VIDA is proud to provide quantitative imaging analysis for #SARP and many commercial clinical trials, with a goal to accelerate the approval of new therapies to those suffering with asthma. If you missed our webinar with pulmonologist and asthma luminary Mario Castro, MD, here are some highlight clips: https://hubs.la/Q02wphpG0 #asthma #digitalbiomarkers

Dr James Pearson's #research, one of the #Type1DiabetesGrandChallenge funded projects, a collaboration between the Steve Morgan Foundation, Diabetes UK and JDRF UK, explores if the time of day we give #Type1Diabetes treatments helps to protect beta cells. Dr Pearson will give mice a treatment either in the morning or the evening to find out what time of day is best for keeping beta cells safe. This knowledge will help to improve the success of therapies for people with, and at risk of, #T1D by identifying when best to administer treatments. Learn more: https://lnkd.in/gd7Ku22b 

Revolutionizing Diabetes Care: New Insights into Old Diabetes Drug Exciting News in Diabetes Research! Researchers at the University of California San Diego School of Medicine have uncovered new insights into an old diabetes drug, Thiazolidinediones (TZDs), once sidelined due to side effects. They've discovered how TZDs work at a molecular level, potentially leading to new, safer treatments for type 2 diabetes. Check out the link for more details on this topic: [link](https://lnkd.in/dQDNWCRU). Join our Diabetes Champions community for updates on this groundbreaking research and more engaging content! #DiabetesResearch #HealthcareInnovation #MedicalResearch #Type2Diabetes #UCSanDiegoMedicine

Risamkizimab achieves both primary endpoints! Dr. Tauseef Ali, Medical Executive Director, SSM Health Digestive Care and SSM Health Crohn's and Colitis Center shared exciting findings of the SEQUENCE Phase 3 study comparing Risankizumab to Ustekinumab for treating adults with active Crohn's disease after anti-TNF therapy. Remarkably, Risankizumab achieved both primary endpoints, demonstrating: - Non-inferiority for clinical remission at week 24 - Superiority in endoscopic remission at week 48 compared to Ustekinumab AbbVie Learn more: https://lnkd.in/dwdcGzwX #CrohnsDisease #MedicalBreakthrough

Lung function tests are essential to evaluate the core functioning of the lungs. By assessing PFTs, which include lung volumes, lung capacities, rates of flow, and gas exchange, physicians get the information that aids in diagnosing multiple lung disorders, especially COPD. Technological developments are expected to have a huge impact on the market. High investments by the key market players for the extensive research and development of novel and advanced diagnostic and monitoring technologies are expected to enable the early diagnosis of COPD. #Lungfunction #Respiratory #COPD #Feellife

Are you passionate about diabetes management and improving patient outcomes? Look no further! At ARKRAY, we understand the critical importance of reliable diagnostic tools in the fight against diabetes. That's why our Adams Instruments follow the golden standard for diagnosing and monitoring this condition. The HA-8190V with a high Accuracy and Precision will help you in making a positive impact on the lives of patients with diabetes. Time is of the essence in healthcare, and the HA-8190V is here to streamline your workflow and boost productivity. With its efficient operation and rapid results, you can optimize your processes. But that's not all. The HA-8190V is capable to recognise important variants, like the Hemoglobin S variant , associated with the condition of sickle cell anemia .  In today's fast-changing world, where global migration become almost standard, this capability is more crucial than ever.  Join us in revolutionizing diabetes care and beyond with the Adams Instrument HA-8190V. Together, we can make a difference in the lives of patients worldwide. #Arkray #DiabetesManagement #AdamsInstrument #HealthcareInnovation #BetterPatientCare

On September 15, Cynthia Pussinen, our newly appointed Chief Executive Officer, and Modestus Obochi, PhD MBA, our Chief Business Officer, will be introduced during a webcast. Together, they will discuss the overall vision they share to deliver novel medical therapies to patients with chronic diseases. On October 5, we will host another webcast to provide a business update and discuss our strategy and operating plans for the future. Learn how to join the webcasts here: https://lnkd.in/eypCQwNK #CellTherapy #CEO #T1D #Type1Diabetes #Diabetes #HemophiliaA #Hypothyroidism